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Determination of blood-brain barrier (BBB) integrity is of substantial interest to researchers in 
several fields, including multiple sclerosis (MS), ageing, cerebral small vessel disease, stroke and 
dementia. A validated, reliable and minimally-invasive technique for in-vivo quantification is 
therefore a highly desirable goal. Although several imaging and biochemical techniques exist, 
dynamic contrast-enhanced (DCE-) magnetic resonance imaging (MRI) is considered the most useful 
for clinical research applications at present (Heye et al., 2014), since it provides quantitative 
estimates of contrast agent leakage at moderate spatial resolution, and is relatively convenient and 
safe if relevant guidance is followed. Briefly, a solution of paramagnetic gadolinium complex is 
injected intravenously, which enters the brain’s capillaries and from there may leak across the BBB 
into the extracellular extravascular space. This uptake is detected via an increase in the T1-weighted 
MRI signal intensity, typically measured over a period of several minutes or longer. Image analysis 
methods can be used to estimate vascular properties including the cerebral blood volume (CBV or 
vB) and contrast agent leakage rate across the vessel wall (reported variously as K
Trans, Ki and PS) from 
the time-signal profile. 
Despite widespread application of DCE-MRI in neuro-oncology and body imaging, measurement of 
leakage across relatively intact BBB is less common and is acknowledged to be difficult: leakage is 
slow, resulting in very small signal changes – typically five percent or lower over twenty minutes. The 
precision and accuracy of quantification are limited by noise, artefact, the temporal stability of MRI 
scanners and by assumptions inherent in the data modelling. In the language of quantitative imaging 
biomarkers, there is growing  (e.g. (Wong et al., 2017)) but limited evidence supporting the technical 
and biological validity; such evidence is difficult to obtain due to the need to administer repeat doses 
of contrast agent and the lack of suitable reference methods. 
The article by Varatharaj et al. published in the current issue of Journal of Physiology therefore 
contributes welcome proof-of-principle evidence of biological validity. They performed DCE-MRI in 
MS subjects and in healthy controls. Specifically, they report a grey matter- (GM) white matter (WM) 
CBV ratio of around 2, greater BBB leakage rate in contrast-enhancing MS lesions versus normal-
appearing WM and greater leakage rate in the normal-appearing WM of MS subjects versus that of 
healthy controls – findings that are consistent with reasonable biological expectation. The authors 
also report faster leakage in GM compared with WM in healthy controls, plausibly suggesting that 
the greater CBV in GM corresponds to higher vascular surface area and therefore more overall 
leakage per unit tissue volume, assuming equal permeability and vessel radius in the two tissues. 
Whether or not this is the actual reason, it emphasises the important subtlety that DCE-MRI at best 
quantifies PS, the capillary surface area per unit volume multiplied by the permeability, not the 
permeability per se. Vascular surface area is also difficult to measure in-vivo, and the potential 
influence of vascularity on PS may be especially relevant in studies of cerebrovascular diseases and 
in cohorts spanning a wide age range. The difficulty of probing low-level BBB leakage is also nicely 
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illustrated in the article: signal changes that are small in relation to the temporal noise level (Figure 
3) will be familiar to fellow researchers in the field, as will the phenomenon of negative Ki estimates 
(Figure 4). 
An additional challenge to obtaining and interpreting BBB leakage data is the methodological 
heterogeneity found in the literature, with regard to both data acquisition and image analysis 
methods, which range from qualitative visual evaluation of permeability to various quantitative and 
semi-quantitative methods. Partly as a consequence, leakage values reported by different groups are 
often highly dissimilar or simply impossible to compare. Nevertheless, there is a growing consensus 
in favour of the approach exemplified by Varatharaj et al., which included pre-injection 
measurement of the T1 relaxation time and pharmacokinetic analysis of the data using the Patlak 
model. It is an approach that has been developed and tested by the authors and by other groups 
over many years (Larsson et al., 2009; Barnes et al., 2016; Heye et al., 2016), and has advantages 
over simpler methods (e.g. signal enhancement at a single time point or area-under-curve 
calculation) since it aims to correct for protocol-dependent factors and to distinguish between intra- 
and extra-vascular contrast agent. On some aspects, however, such as measurement of contrast 
agent concentration in blood (the “vascular input function”), and temporal resolution, practice 
remains varied. 
The time is arguably now ripe for development of consensus-based multi-vendor MRI protocols for 
more standardised measurement of BBB leakage, coupled with further efforts towards quantitative 
imaging biomarker validation. One such harmonisation initiative is currently underway in the context 
of cerebral small vessel disease (https://harness-neuroimaging.org). This should help facilitate the 
larger, multi-centre studies required to investigate BBB pathophysiology. Parallel development of 
DCE-MRI and of other methods for probing the BBB, including those measuring transvascular water 
exchange, is also eagerly anticipated. 
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